Office of Cancer Centers logo

FAQs | Site Map

  • Cancer Centers  
    • a Cancer Center
    • a Research Program
    • a Shared Resource
    • Skip to content
    • Benchmark Data
    • Data Table 1
    • Data Table 2
    • Data Table 3
    • Data Table 4
  • Grants & Funding  
    • Issuance of PAR-20-043
    • Frequently Asked Questions
    • PRMS and CPDM Guidance
    • Peer Review Process
    Skip to content
    • Policy on Peer Review of DMSP
    • DSMP Review by NCI Staff
    • ICD 10
    • Data Guide v3.1
    • eData v3.1.1
    • eData Templates
    • RPPR Instructions
  • News & Events  
    • OCC Announcements  
  • Policies & Resources  
    • Peer Reviev Funding Systems
    • Cancer Center Identity Badges
    • CTSA
    • Skip to content
    • External Links:
    • NIH RePORT
    • The Cancer Control Planet
    • NCI Fact Book
    • Office of Extramural Research
    • PHS 2590
    • SF 424
    • The Cancer Control Planet
    • External Website Policy
  • About Us  
    • Meet Our Team
    • View Our History
    • Contact Us
    • Skip to content
    • Site Map
    • Keyboard Shortcuts
DT3

 Data Table 3

 Reportable Patients/Participation in Therapeutic Studies


  • Home
  • Cancer Centers
  • Benchmark Data
  • Data Table 3

Press F5 to reset the data table

Note: All values are from data submitted annually by Centers starting from 2010 to recent year.

  • Newly Registered & Newly Enrolled
  • Top 20 Disease Sites for Newly Registered
  • Top 20 Disease Sites for Newly Enrolled

The table below lists the high, low, median, total number of patients newly registered, and total number of patients newly enrolled on interventional therapeutic protocols at NCI-designated Clinical and Comprehensive Cancer Centers during the 12-month reporting period starting from 2010 to recent year.

FY Type of Center Range           Registered           Patients      Enrolled      Patients
2019 14 Clinical Centers High 4,893 0
2019 Low 2,296 0
2019 Median 3,823 0
2019 Subtotal 44,772 0
2019 49 Comp Centers High 24,466 861
2019 Low 545 0
2019 Median 5,383 0
2019 Subtotal 342,643 861
2019 Total 387,415 861
2018 14 Clinical Centers High 4,539 0
2018 Low 2,271 0
2018 Median 3,625 0
2018 Subtotal 40,398 0
2018 49 Comp Centers High 22,567 861
2018 Low 516 0
2018 Median 5,056 0
2018 Subtotal 322,342 2,000
2018 Total 362,740 2,000
2017 15 Clinical Centers High 4,581 451
2017 Low 2,125 0
2017 Median 3,457 193
2017 Subtotal 34,061 1,907
2017 47 Comp Centers High 22,255 5,236
2017 Low 503 0
2017 Median 4,809 0
2017 Subtotal 302,506 22,651
2017 Total 336,567 24,558
2016 17 Clinical Centers High 4,567 397
2016 Low 1,965 94
2016 Median 3,538 259
2016 Subtotal 38,434 2,724
2016 45 Comp Centers High 21,575 6,048
2016 Low 503 129
2016 Median 4,573 605
2016 Subtotal 293,609 43,893
2016 Total 332,043 46,617
2015 17 Clinical Centers High 7,550 704
2015 Low 2,065 114
2015 Median 3,751 322
2015 Subtotal 61,714 4,777
2015 45 Comp Centers High 24,429 6,199
2015 Low 488 124
2015 Median 4,701 579
2015 Subtotal 291,371 41,755
2015 Total 353,085 46,532
2014 20 Clinical Centers High 5,622 615
2014 Low 1,638 69
2014 Median 3,360 300
2014 Subtotal 47,651 4,121
2014 41 Comp Centers High 24,537 6,568
2014 Low 0 162
2014 Median 4,063 590
2014 Subtotal 269,861 40,704
2014 Total 317,512 44,825
2013 20 Clinical Centers High 7,208 756
2013 Low 1,865 161
2013 Median 3,426 305
2013 Subtotal 75,235 7,472
2013 41 Comp Centers High 23,595 6,675
2013 Low 290 84
2013 Median 4,201 512
2013 Subtotal 224,687 35,425
2013 Total 299,922 42,897
2012 19 Clinical Centers High 5,469 732
2012 Low 1,846 67
2012 Median 2,973 316
2012 Subtotal 64,510 7,272
2012 41 Comp Centers High 23,595 6,675
2012 Low 485 202
2012 Median 3,825 535
2012 Subtotal 230,085 35,240
2012 Total 294,595 42,512
2011 19 Clinical Centers High 6,916 706
2011 Low 1,842 122
2011 Median 3,158 304
2011 Subtotal 63,478 6,570
2011 40 Comp Centers High 21,996 7,475
2011 Low 451 202
2011 Median 3,786 636
2011 Subtotal 218,696 42,074
2011 Total 282,174 48,644
2010 19 Clinical Centers High 6,711 698
2010 Low 1,842 127
2010 Median 2,922 293
2010 Subtotal 61,994 6,818
2010 40 Comp Centers High 21,350 7,055
2010 Low 457 235
2010 Median 3,827 607
2010 Subtotal 212,132 35,226
2010 Total 274,126 42,044


The table below lists the top 20 anatomic cancer sites for newly registered patients in the 12-month reporting period starting from 2010 to recent year at NCI-designated Clinical and Comprehensive Cancer Centers.

FY FY Primary Site Registered Patients
2019 Breast 56,588
2019 Prostate 39,611
2019 Lung 34,977
2019 Melanoma, Skin 23,706
2019 Non-Hodgkin Lymphoma 15,484
2019 Colon 15,220
2019 Lip, Oral Cavity and Pharynx 14,248
2019 Brain and Nervous System 13,819
2019 Kidney 13,714
2019 Thyroid 12,566
2019 Pancreas 12,557
2019 Corpus Uteri 11,984
2019 Urinary Bladder 11,738
2019 Liver 9,352
2019 Multiple Myeloma 8,614
2019 Myeloid and Monocytic Leukemia 7,932
2019 Rectum 7,427
2019 Soft Tissue 6,564
2019 Lymphoid Leukemia 6,522
2019 Stomach 5,619
2018 Breast 50,642
2018 Prostate 34,511
2018 Lung 33,038
2018 Melanoma, Skin 22,379
2018 Non-Hodgkin Lymphoma 14,642
2018 Colon 13,994
2018 Lip, Oral Cavity and Pharynx 13,441
2018 Kidney 12,966
2018 Brain and Nervous System 12,881
2018 Pancreas 12,139
2018 Thyroid 11,717
2018 Corpus Uteri 11,379
2018 Urinary Bladder 11,319
2018 Liver 9,454
2018 Multiple Myeloma 7,821
2018 Rectum 7,406
2018 Myeloid and Monocytic Leukemia 7,306
2018 Soft Tissue 6,649
2018 Lymphoid Leukemia 6,573
2018 Stomach 5,393
2017 Breast 46,496
2017 Prostate 30,787
2017 Lung 30,747
2017 Melanoma, Skin 21,066
2017 Colon 13,030
2017 Non-Hodgkin Lymphoma 12,996
2017 Brain and Nervous System 12,464
2017 Lip, Oral Cavity and Pharynx 12,407
2017 Kidney 11,912
2017 Thyroid 11,351
2017 Corpus Uteri 11,114
2017 Pancreas 10,401
2017 Urinary Bladder 10,009
2017 Liver 9,053
2017 Myeloid and Monocytic Leukemia 7,169
2017 Multiple Myeloma 7,061
2017 Rectum 6,751
2017 Soft Tissue 5,963
2017 Lymphoid Leukemia 5,937
2017 Ovary 5,058
2016 Breast 45,540
2016 Lung 30,534
2016 Prostate 28,671
2016 Melanoma, Skin 20,119
2016 Brain and Nervous System 13,105
2016 Non-Hodgkin Lymphoma 13,040
2016 Colon 12,598
2016 Lip, Oral Cavity and Pharynx 12,242
2016 Kidney 12,110
2016 Thyroid 11,799
2016 Pancreas 11,021
2016 Corpus Uteri 10,412
2016 Urinary Bladder 10,196
2016 Liver 8,774
2016 Myeloid and Monocytic Leukemia 7,092
2016 Rectum 6,873
2016 Multiple Myeloma 6,800
2016 Soft Tissue 5,955
2016 Lymphoid Leukemia 5,592
2016 Stomach 5,154
2015 Breast - Female 48,962
2015 Lung 32,900
2015 Prostate 30,611
2015 Melanoma, Skin 20,580
2015 Non-Hodgkin Lymphoma 14,289
2015 Brain and Nervous System 13,461
2015 Colon 13,434
2015 Kidney 13,300
2015 Lip, Oral Cavity and Pharynx 13,046
2015 Thyroid 12,864
2015 Pancreas 11,918
2015 Corpus Uteri 11,361
2015 Bladder 10,664
2015 Liver 9,123
2015 Rectum 7,557
2015 Myeloid and Monocytic Leukemia 7,521
2015 Multiple Myeloma 7,010
2015 Soft Tissue 6,322
2015 Lymphoid Leukemia 5,882
2015 Ovary 5,703
2014 Breast - Female 44,130
2014 Lung 28,775
2014 Prostate 28,660
2014 Melanoma, Skin 19,283
2014 Non-Hodgkin Lymphoma 12,626
2014 Brain and Nervous System 12,139
2014 Colon 11,937
2014 Kidney 11,707
2014 Thyroid 11,640
2014 Lip, Oral Cavity and Pharynx 11,598
2014 Pancreas 10,432
2014 Corpus Uteri 10,143
2014 Bladder 9,807
2014 Liver 7,948
2014 Myeloid and Monocytic Leukemia 6,642
2014 Rectum 6,529
2014 Multiple Myeloma 6,190
2014 Soft Tissue 5,775
2014 Lymphoid Leukemia 5,251
2014 Ovary 5,223
2013 Breast 39,089
2013 Prostate 29,778
2013 Lung 26,477
2013 Melanoma, Skin 18,552
2013 Non-Hodgkin Lymphoma 12,029
2013 Brain and Nervous System 11,515
2013 Lip, Oral Cavity and Pharynx 11,475
2013 Colon 11,344
2013 Kidney 10,845
2013 Thyroid 10,120
2013 Pancreas 9,771
2013 Corpus Uteri 9,221
2013 Bladder 8,805
2013 Liver 7,222
2013 Myeloid and Monocytic Leukemia 6,046
2013 Rectum 6,014
2013 Multiple Myeloma 5,551
2013 Soft Tissue 5,389
2013 Lymphoid Leukemia 4,946
2013 Ovary 4,877
2012 Breast – Female 38,473
2012 Prostate 31,414
2012 Lung 26,168
2012 Melanoma, Skin 17,587
2012 Non-Hodgkin Lymphoma 11,875
2012 Brain and Nervous System 11,786
2012 Colon 11,409
2012 Lip, Oral Cavity and Pharynx 10,762
2012 Kidney 10,505
2012 Thyroid 9,385
2012 Pancreas 9,130
2012 Corpus Uteri 8,977
2012 Bladder 8,371
2012 Liver 6,809
2012 Rectum 6,189
2012 Myeloid and Monocytic Leukemia 6,016
2012 Soft Tissue 5,493
2012 Multiple Myeloma 5,356
2012 Ovary 5,123
2012 Lymphoid Leukemia 4,976
2011 Breast - Female 35,881
2011 Prostate 28,817
2011 Lung 24,386
2011 Melanoma, skin 15,129
2011 Brain and Nervous System 10,724
2011 Non-Hodgkin's Lymphoma 10,620
2011 Colon 10,584
2011 KIDNEY 9,428
2011 Thyroid 8,713
2011 Pancreas 8,086
2011 Lip, Oral Cavity and Pharynx 7,859
2011 Corpus Uteri 6,252
2011 Urinary Bladder 6,086
2011 Rectum 5,500
2011 Liver 5,490
2011 Soft Tissue 4,990
2011 Myeloid and Monocytic Leukemia 4,751
2011 Multiple Myeloma 4,435
2011 Ovary 4,429
2011 Stomach 3,989
2010 Breast - Female 36,367
2010 Prostate 31,239
2010 Lung 24,642
2010 Melanoma, skin 15,857
2010 Brain and Nervous System 11,074
2010 Colon 10,975
2010 Non-Hodgkin’s Lymphoma 10,459
2010 Lip, Oral Cavity and Pharynx 9,577
2010 Kidney 9,527
2010 Pancreas 8,752
2010 Corpus Uteri 8,258
2010 Thyroid 8,227
2010 Bladder 7,583
2010 Liver 5,700
2010 Rectum 5,456
2010 Soft Tissue 5,238
2010 Myeloid and Monocytic Leukemia 5,200
2010 Ovary 4,853
2010 Lymphoid Leukemia 4,379
2010 Esophagus 4,027

The table below lists the top 20 anatomic cancer sites for newly enrolled patients in the 12-month reporting period starting from 2010 to recent year at NCI-designated Clinical and Comprehensive Cancer Centerss.

FY Primary Site Enrolled Patients
2019 Non-Hodgkin Lymphoma 149
2019 Breast 83
2019 Myeloid and Monocytic Leukemia 80
2019 Hodgkin Lymphoma 54
2019 Colon 51
2019 Lung 49
2019 Multiple Myeloma 48
2019 Lymphoid Leukemia 46
2019 Kidney 45
2019 Brain and Nervous System 37
2019 Prostate 31
2019 Urinary Bladder 27
2019 Ovary 26
2019 Pancreas 22
2019 Lip, Oral Cavity and Pharynx 19
2019 Mycosis Fungoides 17
2019 Other Hematopoietic 15
2019 Melanoma, Skin 10
2019 Stomach 9
2019 Soft Tissue 8
2018 Breast 266
2018 Non-Hodgkin Lymphoma 199
2018 Lung 168
2018 Myeloid and Monocytic Leukemia 137
2018 Prostate 119
2018 Multiple Myeloma 111
2018 Urinary Bladder 110
2018 Melanoma, Skin 108
2018 Lymphoid Leukemia 86
2018 Colon 82
2018 Hodgkin Lymphoma 71
2018 Brain and Nervous System 70
2018 Kidney 66
2018 Ovary 57
2018 Pancreas 52
2018 Other Hematopoietic 38
2018 Lip, Oral Cavity and Pharynx 31
2018 Liver 24
2018 Other Digestive Organ 19
2018 Stomach 19
2017 Breast 2,741
2017 Lung 2,031
2017 Prostate 1,782
2017 Myeloid and Monocytic Leukemia 1,587
2017 Non-Hodgkin Lymphoma 1,390
2017 Brain and Nervous System 1,248
2017 Lymphoid Leukemia 1,051
2017 Lip, Oral Cavity and Pharynx 901
2017 Melanoma, Skin 889
2017 Multiple Myeloma 883
2017 Ovary 788
2017 Pancreas 779
2017 Colon 771
2017 Other Hematopoietic 682
2017 Liver 673
2017 Kidney 647
2017 Soft Tissue 611
2017 Urinary Bladder 586
2017 Unknown Sites 529
2017 Esophagus 416
2016 Breast 5,599
2016 Lung 4,261
2016 Prostate 3,344
2016 Myeloid and Monocytic Leukemia 3,046
2016 Lymphoid Leukemia 2,337
2016 Multiple Myeloma 2,243
2016 Brain and Nervous System 2,234
2016 Non-Hodgkin Lymphoma 2,166
2016 Pancreas 1,808
2016 Colon 1,782
2016 Lip, Oral Cavity and Pharynx 1,752
2016 Melanoma, Skin 1,691
2016 Kidney 1,449
2016 Ovary 1,373
2016 Other Hematopoietic 1,358
2016 Soft Tissue 1,206
2016 Urinary Bladder 1,137
2016 Liver 1,116
2016 Hodgkin Lymphoma 584
2016 Rectum 580
2015 Breast - Female 6,048
2015 Lung 4,092
2015 Prostate 3,455
2015 Myeloid and Monocytic Leukemia 3,424
2015 Lymphoid Leukemia 2,466
2015 Brain and Nervous System 2,298
2015 Non-Hodgkin Lymphoma 2,263
2015 Melanoma, Skin 2,078
2015 Multiple Myeloma 2,050
2015 Colon 1,661
2015 Pancreas 1,579
2015 Other Hematopoietic 1,506
2015 Kidney 1,409
2015 Lip, Oral Cavity and Pharynx 1,364
2015 Ovary 1,364
2015 Soft Tissue 1,071
2015 Liver 986
2015 Bladder 776
2015 Hodgkin Lymphoma 674
2015 Corpus Uteri 535
2014 Breast - Female 5,961
2014 Lung 3,816
2014 Prostate 3,353
2014 Myeloid and Monocytic Leukemia 3,272
2014 Lymphoid Leukemia 2,588
2014 Brain and Nervous System 2,357
2014 Non-Hodgkin Lymphoma 2,126
2014 Melanoma, Skin 2,104
2014 Multiple Myeloma 1,919
2014 Colon 1,460
2014 Ovary 1,456
2014 Pancreas 1,400
2014 Kidney 1,321
2014 Other Hematopoietic 1,292
2014 Lip, Oral Cavity and Pharynx 1,266
2014 Soft Tissue 1,184
2014 Liver 897
2014 Bladder 657
2014 Leukemia, other 571
2014 Unknown Sites 542
2013 Breast 5,456
2013 Lung 3,440
2013 Prostate 3,430
2013 Myeloid and Monocytic Leukemia 2,902
2013 Lymphoid Leukemia 2,351
2013 Brain and Nervous System 2,108
2013 Non-Hodgkin Lymphoma 2,018
2013 Melanoma, Skin 1,752
2013 Pancreas 1,698
2013 Multiple Myeloma 1,574
2013 Colon 1,524
2013 Ovary 1,301
2013 Kidney 1,159
2013 Other Hematopoietic 1,154
2013 Lip, Oral Cavity and Pharynx 1,150
2013 Soft Tissue 1,017
2013 Liver 1,014
2013 Bladder 706
2013 Hodgkin Lymphoma 638
2013 Corpus Uteri 634
2012 Breast – Female 5,697
2012 Prostate 3,629
2012 Lung 3,605
2012 Myeloid and Monocytic Leukemia 2,682
2012 Brain and Nervous System 2,380
2012 Melanoma, Skin 2,295
2012 Lymphoid Leukemia 2,097
2012 Non-Hodgkin Lymphoma 1,841
2012 Multiple Myeloma 1,667
2012 Colon 1,550
2012 Pancreas 1,432
2012 Other Hematopoietic 1,210
2012 Ovary 1,205
2012 Lip, Oral Cavity and Pharynx 1,142
2012 Soft Tissue 1,005
2012 Kidney 953
2012 Liver 924
2012 Hodgkin Lymphoma 678
2012 Rectum 598
2012 Corpus Uteri 572
2011 Breast - Female 6,214
2011 Lung 3,967
2011 Prostate 3,119
2011 Myeloid and Monocytic Leukemia 2,453
2011 Brain and Nervous System 2,294
2011 Melanoma, skin 2,290
2011 Non-Hodgkin's Lymphoma 1,841
2011 Lymphoid Leukemia 1,811
2011 Colon 1,474
2011 Pancreas 1,348
2011 Multiple Myeloma 1,303
2011 Ovary 1,283
2011 Lip, Oral Cavity and Pharynx 1,220
2011 Other Hematopoietic 1,158
2011 KIDNEY 1,049
2011 Soft Tissue 985
2011 Liver 721
2011 Urinary Bladder 552
2011 Rectum 530
2011 Bones and Joints 470
2010 Breast - Female 6,728
2010 Lung 3,488
2010 Prostate 3,067
2010 Myeloid and Monocytic Leukemia 2,852
2010 Brain and Nervous System 2,220
2010 Melanoma, skin 2,061
2010 Non-Hodgkin’s Lymphoma 2,053
2010 Lymphoid Leukemia 1,906
2010 Multiple Myeloma 1,491
2010 Colon 1,408
2010 Ovary 1,259
2010 Pancreas 1,251
2010 Kidney 1,123
2010 Soft Tissue 1,072
2010 Lip, Oral Cavity and Pharynx 990
2010 Other Hematopoietic 981
2010 Hodgkin’s Lymphoma 633
2010 Bladder 569
2010 Liver 549
2010 Bones and Joints 546

Home|Contact Us|Accessibility|FOIA

U.S. Department of Health and Human Services|National Institutes of Health|National Cancer Institute|USA.gov

NIH…Turning Discovery Into Health®

2021 - The Office Of Cancer Centers at NCI